Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
463
Total Claims
$743K
Drug Cost
77
Beneficiaries
$9,649
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,536 Allergy/ Immunology providers
+175%
Cost per patient vs peers
$9,649 vs $3,515 avg
+110%
Brand preference vs peers
57.2% vs 27.3% avg
Brand vs Generic
Brand: 265 claims · $737K
Generic: 198 claims · $6,081
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Omalizumab | 97 | $354K |
| Dupilumab | 52 | $220K |
| Mepolizumab | 23 | $89K |
| Fluticasone Propion/Salmeterol | 15 | $8,305 |
| Azelastine Hcl | 39 | $1,472 |
| Fluticasone Propionate | 35 | $579 |
| Ipratropium Bromide | 13 | $567 |
| Montelukast Sodium | 26 | $501 |
| Levocetirizine Dihydrochloride | 13 | $119 |
| Prednisone | 22 | $42 |
Prescribing Profile
10
Unique Drugs
3.0
Anomaly Score
Patient Profile
68
Avg Age
77%
Female
1.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About